デフォルト表紙
市場調査レポート
商品コード
1451681

In Vitro診断市場レポート:検査タイプ、製品、ユーザビリティ、用途、エンドユーザー、地域別、2024-2032

In Vitro Diagnostics Market Report by Test Type, Product, Usability, Application, End User, and Region 2024-2032

出版日: | 発行: IMARC | ページ情報: 英文 141 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
In Vitro診断市場レポート:検査タイプ、製品、ユーザビリティ、用途、エンドユーザー、地域別、2024-2032
出版日: 2024年03月02日
発行: IMARC
ページ情報: 英文 141 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のIn Vitro診断市場規模は2023年に1,109億米ドルに達しました。今後、IMARC Groupは、同市場が2032年までに1,781億米ドルに達し、2024~2032年の成長率(CAGR)は5.24%になると予測しています。慢性疾患や感染症の蔓延、個別化された医薬品への嗜好の高まり、世界の老人人口の増加、技術の継続的な進歩などが、市場を牽引する主な要因となっています。

In Vitro診断(IVD)とは、血液、尿、組織、その他の体液などのサンプルを用いて、通常は実験室で、生体外で実施される医療検査や処置のことです。これらの検査は、様々な病状や疾患の検出、診断、モニターを目的としています。生体内で行われるin vivo診断とは異なり、in vitro診断では、管理された実験室条件下で生物学的検体を検査します。In Vitro診断用医薬品(IVD)検査は現代のヘルスケアに不可欠なものであり、医療従事者が患者のケアについて十分な情報を得た上で意思決定を行うための重要な情報を提供します。これらの検査は、病気のスクリーニング、早期診断、治療法の選択、治療経過のモニタリングにおいて重要な役割を果たしています。これらの検査は、臨床化学、微生物学、血液学、免疫学、分子診断学など、さまざまな医療専門分野で使用されています。

同市場は、慢性疾患や感染症の有病率の増加に牽引され、大きな成長を遂げています。人口の高齢化とライフスタイルの変化に伴い、糖尿病、心血管疾患、がんなどの慢性疾患が蔓延しています。In Vitro診断は、これらの疾患の早期発見と効果的な管理に関する重要な洞察をヘルスケア専門家に提供し、患者の転帰の改善と医療費の削減につながります。さらに、技術の進歩と自動化の統合がIn Vitro診断用医薬品市場に革命をもたらしました。ポイントオブケア検査装置や分子診断薬などの自動化システムは、診断プロセスを合理化し、より迅速で正確な結果を可能にしました。さらに、個別化医療と精密診断への注目の高まりが、特殊なIn Vitro診断用検査の需要を押し上げています。これらの検査は、個々の患者の遺伝的・分子的特徴に合わせて治療計画を調整し、治療成果を最適化し、副作用を最小限に抑えるのに役立ちます。

In Vitro診断市場の動向と促進要因:

様々な技術の進歩と自動化

技術革新の急速なペースはIn Vitro診断(IVD)市場に革命をもたらしました。分子診断、次世代シーケンシング、マイクロ流体などの先端技術により、より正確で高感度な検査法が可能になった。自動化によって診断プロセスが合理化され、人為的ミスが減り、効率が向上しています。ポイントオブケア検査装置のような自動化システムは、より迅速な結果をもたらし、患者ケアにおけるタイムリーな意思決定を可能にしています。こうした進歩は診断精度を高めるだけでなく、コスト削減や患者の転帰改善にも寄与しています。さらに、自動化によって遠隔地や資源に乏しい地域にも診断検査が行き届くようになり、ヘルスケア格差に対処し、必要不可欠な診断サービスへの患者のアクセスを改善しています。人工知能と機械学習アルゴリズムの統合により、診断システムの分析能力はさらに向上し、より正確でパーソナライズされた検査解釈が可能になりました。技術の進歩に伴い、In Vitro診断市場は継続的な成長が見込まれ、診断検査とアプリケーションの範囲はますます拡大しています。

慢性疾患の増加

糖尿病、心血管疾患、がんなどの慢性疾患の有病率の増加は、In Vitro診断用医薬品市場の成長を牽引する重要な要因となっています。人口の高齢化とライフスタイルの変化に伴い、慢性疾患は世界的に蔓延しています。In Vitro診断は、これらの疾患の早期発見、モニタリング、管理において重要な役割を果たしています。診断検査は、ヘルスケア専門家が十分な情報に基づき治療方針を決定するのを支援し、より良い疾病管理と患者のQOL向上につながります。さらに、慢性疾患の蔓延は予防医療へのパラダイムシフトを促しています。早期発見と早期介入は、慢性疾患の進行を防ぎ、ヘルスケアシステムの負担を軽減するために不可欠です。In Vitro診断は、早期スクリーニングと危険因子の特定を容易にし、タイムリーな予防措置を可能にします。このような予防医療の重視は、日常的な健康診断やウェルネス・プログラムにおけるIn Vitro診断用医薬品の採用に拍車をかけています。

個別化医療の重視

個別化医療への注目の高まりは、In Vitro診断用医薬品市場に大きな影響を与えています。個別化医療は、遺伝的体質、ライフスタイル、その他の要因に基づいて、個々の患者に合った医療を提供することを目的としています。遺伝子検査やコンパニオン診断などのIn Vitro診断は、患者固有の特性に関する重要な洞察を提供し、的を絞った治療を可能にし、不必要な治療や副作用を回避します。次世代シーケンシング(NGS)やコンパニオン診断のような先端技術によって可能になる精密診断は、特定の疾患サブタイプや分子標的の同定を容易にします。精密医療が脚光を浴びるにつれ、特殊な診断検査に対する需要は増加の一途をたどっています。ヘルスケアプロバイダーや製薬会社は、新たなバイオマーカーを同定し、精密医療イニシアチブをサポートする革新的な診断ソリューションを創出するための研究開発への投資を増やしています。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界のIn Vitro診断市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳:検査タイプ別

  • 臨床化学
    • 市場動向
    • 市場予測
  • 分子診断
    • 市場動向
    • 市場予測
  • 免疫診断
    • 市場動向
    • 市場予測
  • 血液学
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 市場内訳:製品別

  • 試薬・キット
    • 市場動向
    • 市場予測
  • 機器
    • 市場動向
    • 市場予測

第8章 市場内訳:ユーザビリティ別

  • ディスポーザブルIVDデバイス
    • 市場動向
    • 市場予測
  • リユーザブルIVDデバイス
    • 市場動向
    • 市場予測

第9章 市場内訳:用途別

  • 感染症
    • 市場動向
    • 市場予測
  • 糖尿病
    • 市場動向
    • 市場予測
  • がん/腫瘍
    • 市場動向
    • 市場予測
  • 循環器領域
    • 市場動向
    • 市場予測
  • 自己免疫疾患
    • 市場動向
    • 市場予測
  • 腎臓内科
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 市場内訳:エンドユーザー別

  • 病院研究所
    • 市場動向
    • 市場予測
  • 臨床検査
    • 市場動向
    • 市場予測
  • 臨床検査センター
    • 市場動向
    • 市場予測
  • 学術機関
    • 市場動向
    • 市場予測
  • 患者
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第11章 市場内訳:地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳:国別
    • 市場予測

第12章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第13章 バリューチェーン分析

第14章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第15章 価格分析

第16章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Agilent Technologies Inc.
    • Biomerieux SA
    • Bio-Rad Laboratories Inc.
    • F. Hoffmann-La Roche Ltd
    • Fujifilm Holdings Corporation
    • Illumina Inc.
    • Qiagen NV
    • Quest Diagnostics
    • Shimadzu Corporation
    • Siemens Healthcare GmbH
    • Sysmex Corporation
図表

List of Figures

  • Figure 1: Global: In Vitro Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: In Vitro Diagnostics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: In Vitro Diagnostics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: In Vitro Diagnostics Market: Breakup by Test Type (in %), 2023
  • Figure 5: Global: In Vitro Diagnostics Market: Breakup by Product (in %), 2023
  • Figure 6: Global: In Vitro Diagnostics Market: Breakup by Usability (in %), 2023
  • Figure 7: Global: In Vitro Diagnostics Market: Breakup by Application (in %), 2023
  • Figure 8: Global: In Vitro Diagnostics Market: Breakup by End User (in %), 2023
  • Figure 9: Global: In Vitro Diagnostics Market: Breakup by Region (in %), 2023
  • Figure 10: Global: In Vitro Diagnostics (Clinical Chemistry) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: In Vitro Diagnostics (Clinical Chemistry) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: In Vitro Diagnostics (Molecular Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: In Vitro Diagnostics (Molecular Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: In Vitro Diagnostics (Immunodiagnostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: In Vitro Diagnostics (Immunodiagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: In Vitro Diagnostics (Hematology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: In Vitro Diagnostics (Hematology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: In Vitro Diagnostics (Other Test Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: In Vitro Diagnostics (Other Test Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: In Vitro Diagnostics (Reagents and Kits) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: In Vitro Diagnostics (Reagents and Kits) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: In Vitro Diagnostics (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: In Vitro Diagnostics (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: In Vitro Diagnostics (Disposable IVD Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: In Vitro Diagnostics (Disposable IVD Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: In Vitro Diagnostics (Reusable IVD Devices) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: In Vitro Diagnostics (Reusable IVD Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: In Vitro Diagnostics (Infectious Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: In Vitro Diagnostics (Infectious Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: In Vitro Diagnostics (Diabetes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: In Vitro Diagnostics (Diabetes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: In Vitro Diagnostics (Cancer/Oncology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: In Vitro Diagnostics (Cancer/Oncology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: In Vitro Diagnostics (Cardiology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: In Vitro Diagnostics (Cardiology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: In Vitro Diagnostics (Autoimmune Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: In Vitro Diagnostics (Autoimmune Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: In Vitro Diagnostics (Nephrology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: In Vitro Diagnostics (Nephrology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Global: In Vitro Diagnostics (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Global: In Vitro Diagnostics (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Global: In Vitro Diagnostics (Hospitals Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Global: In Vitro Diagnostics (Hospitals Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Global: In Vitro Diagnostics (Clinical Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Global: In Vitro Diagnostics (Clinical Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Global: In Vitro Diagnostics (Point-of-care Testing Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Global: In Vitro Diagnostics (Point-of-care Testing Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Global: In Vitro Diagnostics (Academic Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Global: In Vitro Diagnostics (Academic Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Global: In Vitro Diagnostics (Patients) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Global: In Vitro Diagnostics (Patients) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Global: In Vitro Diagnostics (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Global: In Vitro Diagnostics (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: North America: In Vitro Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: North America: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: United States: In Vitro Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: United States: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Canada: In Vitro Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Canada: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Asia-Pacific: In Vitro Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Asia-Pacific: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: China: In Vitro Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: China: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Japan: In Vitro Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Japan: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: India: In Vitro Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: India: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: South Korea: In Vitro Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: South Korea: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Australia: In Vitro Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Australia: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Indonesia: In Vitro Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Indonesia: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Others: In Vitro Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Others: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Europe: In Vitro Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Europe: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Germany: In Vitro Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Germany: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: France: In Vitro Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: France: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: United Kingdom: In Vitro Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: United Kingdom: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Italy: In Vitro Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Italy: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Spain: In Vitro Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Spain: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Russia: In Vitro Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 89: Russia: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 90: Others: In Vitro Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 91: Others: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 92: Latin America: In Vitro Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 93: Latin America: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 94: Brazil: In Vitro Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 95: Brazil: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 96: Mexico: In Vitro Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 97: Mexico: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 98: Others: In Vitro Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 99: Others: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 100: Middle East and Africa: In Vitro Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 101: Middle East and Africa: In Vitro Diagnostics Market: Breakup by Country (in %), 2023
  • Figure 102: Middle East and Africa: In Vitro Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 103: Global: In Vitro Diagnostics Industry: SWOT Analysis
  • Figure 104: Global: In Vitro Diagnostics Industry: Value Chain Analysis
  • Figure 105: Global: In Vitro Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: In Vitro Diagnostics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: In Vitro Diagnostics Market Forecast: Breakup by Test Type (in Million US$), 2024-2032
  • Table 3: Global: In Vitro Diagnostics Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 4: Global: In Vitro Diagnostics Market Forecast: Breakup by Usability (in Million US$), 2024-2032
  • Table 5: Global: In Vitro Diagnostics Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 6: Global: In Vitro Diagnostics Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 7: Global: In Vitro Diagnostics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: In Vitro Diagnostics Market: Competitive Structure
  • Table 9: Global: In Vitro Diagnostics Market: Key Players
目次
Product Code: SR112024A6467

The global in vitro diagnostics market size reached US$ 110.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 178.1 Billion by 2032, exhibiting a growth rate (CAGR) of 5.24% during 2024-2032. The growing prevalence of chronic and infectious diseases, the rising preference for personalized medicines, the rising geriatric population across the globe, and continuous advancements in technologies represent some of the key factors driving the market.

In vitro diagnostics (IVD) refers to medical tests and procedures that are performed outside the living organism, typically in a laboratory setting, using samples such as blood, urine, tissue, or other body fluids. These tests are designed to detect, diagnose, and monitor various medical conditions and diseases. Unlike in vivo diagnostics, which are conducted within the living body, in vitro diagnostics involve the examination of biological specimens in controlled laboratory conditions. IVD tests are an integral part of modern healthcare, providing crucial information to healthcare professionals for making informed decisions about patient care. These tests play a vital role in disease screening, early diagnosis, treatment selection, and monitoring treatment progress. They are used across various medical specialties, including clinical chemistry, microbiology, hematology, immunology, molecular diagnostics, and more.

The market is experiencing significant growth, driven by the increasing prevalence of chronic diseases and infectious conditions. With the rise in aging populations and lifestyle changes, chronic diseases such as diabetes, cardiovascular disorders, and cancer have become more prevalent. In vitro diagnostics provide healthcare professionals with essential insights into the early detection and effective management of these conditions, leading to improved patient outcomes and reduced healthcare costs. Moreover, advancements in technology and the integration of automation have revolutionized the IVD market. Automated systems, such as point-of-care testing devices and molecular diagnostics, have streamlined the diagnostic process, enabling faster and more accurate results. Additionally, the growing focus on personalized medicine and precision diagnostics has boosted the demand for specialized in vitro diagnostic tests. These tests help tailor treatment plans to individual patients' specific genetic and molecular characteristics, optimizing therapeutic outcomes and minimizing adverse reactions.

In Vitro Diagnostics Market Trends/Drivers:

Various technological advancements and automation

The rapid pace of technological innovation has revolutionized the In vitro diagnostics (IVD) market. Advanced technologies, such as molecular diagnostics, next-generation sequencing, and microfluidics, have enabled more accurate and sensitive testing methods. Automation has streamlined diagnostic processes, reducing human errors and increasing efficiency. Automated systems like point-of-care testing devices have facilitated faster results, enabling timely decision-making in patient care. These advancements not only enhance diagnostic accuracy but also contribute to cost savings and improved patient outcomes. Moreover, automation has extended the reach of diagnostic testing to remote or resource-limited areas, addressing healthcare disparities and improving patient access to essential diagnostic services. The integration of artificial intelligence and machine learning algorithms has further enhanced the analytical capabilities of diagnostic systems, allowing for more precise and personalized test interpretations. As technology continues to advance, the In vitro diagnostics market is expected to witness continued growth, with an ever-expanding range of diagnostic tests and applications.

The increasing prevalence of chronic diseases

The rising prevalence of chronic diseases, such as diabetes, cardiovascular disorders, and cancer, has been a key driver in the growth of the IVD market. With aging populations and lifestyle changes, chronic conditions have become more prevalent globally. In vitro diagnostics play a crucial role in the early detection, monitoring, and management of these diseases. Diagnostic tests assist healthcare professionals in making informed treatment decisions, leading to better disease management and improved quality of life for patients. Moreover, the prevalence of chronic diseases has prompted a paradigm shift towards preventive healthcare. Early detection and intervention are essential in preventing the progression of chronic conditions and reducing the burden on healthcare systems. In vitro diagnostics facilitate early screening and identification of risk factors, enabling timely preventive measures. This emphasis on preventive healthcare has spurred the adoption of IVD tests in routine health check-ups and wellness programs.

The growing emphasis on personalized medicine

The growing focus on personalized medicine has significantly impacted the IVD market. Personalized medicine aims to tailor medical treatment to individual patients based on their genetic makeup, lifestyle, and other factors. In vitro diagnostics, such as genetic testing and companion diagnostics, provide critical insights into patients' unique characteristics, enabling targeted therapies and avoiding unnecessary treatments or adverse reactions. Precision diagnostics, enabled by advanced technologies like Next-Generation Sequencing (NGS) and companion diagnostics, facilitate the identification of specific disease subtypes and molecular targets. As precision medicine gains prominence, the demand for specialized diagnostic tests continues to rise. Healthcare providers and pharmaceutical companies are increasingly investing in research and development to identify new biomarkers and create innovative diagnostic solutions to support precision medicine initiatives.

In Vitro Diagnostics Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global in vitro diagnostics market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on test type, product, usability, application and end user.

Breakup by Test Type:

Clinical Chemistry

Molecular Diagnostics

Immunodiagnostics

Hematology

Others

Molecular diagnostics represents the most popular test type

The report has provided a detailed breakup and analysis of the market based on test type. This includes clinical chemistry, molecular diagnostics, immunodiagnostics, hematology, and others. According to the report, molecular diagnostics represented the largest segment.

Molecular diagnostics offer high levels of accuracy and sensitivity in disease detection. They can identify even low concentrations of target molecules, enabling early diagnosis and precise monitoring of diseases. This level of sensitivity is particularly crucial in the detection of infectious diseases, genetic disorders, and certain types of cancer, where early intervention is vital for successful treatment. Moreover, molecular diagnostics play a key role in the advancement of personalized medicine. By analyzing an individual's genetic makeup or specific biomarkers, these tests can tailor treatment plans to each patient's unique characteristics. This approach optimizes therapeutic outcomes, minimizes adverse effects, and enhances overall patient care, contributing to the growing demand for personalized healthcare solutions.

Breakup by Product:

Reagents and Kits

Instruments

Reagents and kits represent the leading segment

A detailed breakup and analysis of the market based on the product has also been provided in the report. This includes reagents and kits and instruments. According to the report, reagents and kits hold the largest market share.

Reagents and kits are fundamental components of diagnostic tests. They contain the necessary substances and chemicals required to perform specific assays and analyze patient samples. Diagnostic laboratories and healthcare facilities rely heavily on reagents and kits to conduct a wide range of tests, from routine screenings to complex molecular diagnostics. Moreover, Reagents and kits are designed to be user-friendly and standardized, ensuring consistent and reliable results across different laboratories and testing sites. They simplify the testing process, reducing the need for extensive manual preparation and minimizing the risk of errors. Standardization also facilitates inter-laboratory comparability, making it easier for healthcare providers to interpret and act upon test results.

Breakup by Usability:

Disposable IVD Devices

Reusable IVD Devices

The report has provided a detailed breakup and analysis of the market based on usability. This includes disposable IVD devices and reusable IVD devices.

Disposable IVD devices are designed for single-use and are discarded after a single patient interaction or testing procedure. They are pre-sterilized and come in a ready-to-use format, which eliminates the need for cleaning, disinfection, or reprocessing after each use. Healthcare providers find disposable IVD devices convenient and time-saving, as they eliminate the need for complex and time-consuming reprocessing procedures. This is especially advantageous in high-volume testing environments.

Reusable IVD devices, as the name suggests, can be used multiple times after appropriate cleaning, sterilization, and maintenance. They are made of durable materials that can withstand repeated use without compromising their performance. They also offer greater flexibility in terms of test customization and parameter adjustments, making them suitable for research and specialized testing needs.

Breakup by Application:

Infectious Disease

Diabetes

Cancer/Oncology

Cardiology

Autoimmune Disease

Nephrology

Others

Infectious diseases currently dominate the market

A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes infectious disease, diabetes, cancer/oncology, cardiology, autoimmune disease, nephrology, and others. According to the report, infectious diseases accounted for the largest market share.

Infectious diseases pose significant global health challenges, and outbreaks or pandemics can have severe consequences on public health and economies. The COVID-19 pandemic, for example, has highlighted the critical role of diagnostic testing in controlling the spread of infectious diseases. Besides, infectious diseases have a high incidence and prevalence rate, affecting millions of people worldwide. Common infectious diseases such as influenza, tuberculosis, hepatitis, and sexually transmitted infections continue to impact communities across the globe. Moreover, in vitro diagnostics offer a rapid and reliable way to identify infectious agents, allowing healthcare providers to initiate appropriate therapies, implement infection control measures, and prevent further transmission.

Breakup by End User:

Hospitals Laboratories

Clinical Laboratories

Point-of-care Testing Centers

Academic Institutes

Patients

Others

A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes hospitals laboratories, clinical laboratories, point-of-care testing centers, academic institutes, patients, and others.

Hospital laboratories are an essential part of healthcare facilities, providing diagnostic testing services to inpatients and outpatients. These laboratories are equipped with a wide range of IVD instruments and reagents to perform various tests, including clinical chemistry, hematology, microbiology, and immunology. Hospitals rely on timely and accurate diagnostic results from their in-house laboratories to aid in patient diagnosis, treatment, and disease management.

Clinical laboratories, also known as independent or reference laboratories, are separate entities that offer diagnostic testing services to healthcare providers, hospitals, clinics, and other healthcare settings. They often handle high-volume and specialized tests that may not be available in all hospital laboratories. Clinical laboratories serve as centralized testing facilities, supporting multiple healthcare facilities with their comprehensive testing capabilities.

Point-of-care testing (POCT) centers represent a rapidly growing segment in the IVD market. These centers provide diagnostic tests at or near the location where patient care is delivered. POCT devices offer rapid results, allowing for immediate treatment decisions and interventions. Point-of-care testing centers are especially valuable in emergency rooms, ambulances, nursing homes, and remote or resource-limited settings where quick diagnosis is critical.

Academic institutes, including research universities and medical schools, contribute to the IVD market through research, development, and education. They play a pivotal role in advancing diagnostic technologies, discovering new biomarkers, and evaluating the effectiveness of diagnostic tests. Academic institutes often collaborate with diagnostic companies to conduct clinical trials and validate the performance of novel diagnostic assays.

Patients are becoming increasingly involved in their healthcare decisions, including diagnostic testing. The IVD market caters to the direct-to-consumer testing trend, where patients can access certain diagnostic tests without a healthcare provider's prescription. These tests allow individuals to monitor their health status, identify risk factors, and take proactive steps towards better health management.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America accounts for the majority of market share

The report has also provided a comprehensive analysis of all the major regional markets, which includes North America (United States, Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others); Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others); Latin America (Brazil, Mexico, Others); and the Middle East and Africa. According to the report, North America was the largest market for in vitro diagnostics.

North America boasts a well-developed and advanced healthcare infrastructure, including modern hospitals, clinical laboratories, and research institutions. The region's robust healthcare system supports a high volume of diagnostic testing, driving the demand for IVD products and services. Besides, North America is at the forefront of technological innovations in the IVD industry. The region is home to many leading diagnostic companies and research institutions that invest heavily in research and development, leading to the creation of cutting-edge diagnostic technologies and products. Moreover, the region has stringent regulatory standards for diagnostic products, ensuring safety and efficacy. Companies operating in the region must comply with rigorous quality control measures, which helps build trust in the reliability of IVD products.

Competitive Landscape:

The competitive landscape of the In vitro diagnostics (IVD) market is characterized by a diverse and highly competitive environment, with numerous companies vying for market share. They are developing advanced technologies, novel biomarkers, and point-of-care testing devices to meet the evolving needs of the healthcare industry. They are engaging in mergers and acquisitions (M&As) to expand their product portfolios, gain access to new markets, and enhance their technological capabilities. They are also expanding their market presence by establishing distribution networks in new regions or countries. Moreover, companies are embracing digitalization and investing in digital diagnostic solutions. This includes the development of digital pathology, remote monitoring, and telehealth solutions to enhance diagnostic efficiency and accessibility.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbott Laboratories

Agilent Technologies Inc.

Biomerieux SA

Bio-Rad Laboratories Inc.

F. Hoffmann-La Roche Ltd

Fujifilm Holdings Corporation

Illumina Inc.

Qiagen N.V

Quest Diagnostics

Shimadzu Corporation

Siemens Healthcare GmbH

Sysmex Corporation

Recent Developments:

Roche Ltd. launched the Elecsys Anti-SARS-CoV-2 S antibody test, which measures the level of antibodies against the spike protein of the SARS-CoV-2 virus. The test aids in assessing a person's immune response after COVID-19 vaccination or infection.

Abbott Laboratories launched the Panbio COVID-19 Ag Rapid Test Device, a rapid antigen test for COVID-19. The test delivers results within 15 minutes and has been widely used for screening and surveillance purposes during the pandemic.

Siemens Healthineers introduced the Atellica Solution, a fully automated clinical chemistry and immunoassay system. The system offers high throughput, broad assay menu, and enhanced efficiency for clinical laboratories.

Key Questions Answered in This Report

  • 1. What was the size of the global in vitro diagnostics market in 2023?
  • 2. What is the expected growth rate of the global in vitro diagnostics market during 2024-2032?
  • 3. What are the key factors driving the global in vitro diagnostics market?
  • 4. What has been the impact of COVID-19 on the global in vitro diagnostics market?
  • 5. What is the breakup of the global in vitro diagnostics market based on the test type?
  • 6. What is the breakup of the global in vitro diagnostics market based on the product?
  • 7. What is the breakup of the global in vitro diagnostics market based on application?
  • 8. What are the key regions in the global in vitro diagnostics market?
  • 9. Who are the key players/companies in the global in vitro diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global In Vitro Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Test Type

  • 6.1 Clinical Chemistry
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Molecular Diagnostics
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Immunodiagnostics
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Hematology
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Reagents and Kits
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Instruments
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Usability

  • 8.1 Disposable IVD Devices
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Reusable IVD Devices
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Infectious Disease
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Diabetes
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Cancer/Oncology
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Cardiology
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Autoimmune Disease
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast
  • 9.6 Nephrology
    • 9.6.1 Market Trends
    • 9.6.2 Market Forecast
  • 9.7 Others
    • 9.7.1 Market Trends
    • 9.7.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Hospitals Laboratories
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Clinical Laboratories
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Point-of-care Testing Centers
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Academic Institutes
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Patients
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast
  • 10.6 Others
    • 10.6.1 Market Trends
    • 10.6.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Abbott Laboratories
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Agilent Technologies Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 Biomerieux SA
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
      • 16.3.3.4 SWOT Analysis
    • 16.3.4 Bio-Rad Laboratories Inc.
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
      • 16.3.4.4 SWOT Analysis
    • 16.3.5 F. Hoffmann-La Roche Ltd
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 SWOT Analysis
    • 16.3.6 Fujifilm Holdings Corporation
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
      • 16.3.6.4 SWOT Analysis
    • 16.3.7 Illumina Inc.
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 Qiagen NV
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 Quest Diagnostics
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Shimadzu Corporation
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
      • 16.3.10.4 SWOT Analysis
    • 16.3.11 Siemens Healthcare GmbH
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
    • 16.3.12 Sysmex Corporation
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis